Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with John Lai, CEO & President of PetVivo Holdings, Inc., highlighting company insights and future plans.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Providing exceptional products that exceed our clients’ expectations|Yasuhiro Yokota, President,Tokio Marine Asset Management (USA) Ltd.
00:10:00
Helping Financial Advisors Secure Their Future: Brooklyn Brock on Financial Planning and Business Exits | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
DOTD CEO Milan Patel and CFO Paraag Amin provide an overview of the company's full-year results for the period ending June 30, 2021, highlighting key operational achievements and financial performance, and outlining future focus areas​|Milan Patel, CEO of
00:10:00
Financial Experiences | Políglota: Empowering Language Learning in Latin America | LarrainVial Asset Management
00:10:00
Striking Gold: Showcasing Growth at Show Gold in Ghana
00:10:00
Lithium Universe Limited: Refining Strategy and Industry Challenges in North America.
00:10:00
Moonfare's Co-Investment Strategy: Capitalizing on Private Equity Opportunities
00:10:00
Elis, Rings European Trading Day in Paris | Xavier Martiré - Chairman of the Management Board and Chief Executive Officer of Elis SA
00:10:00
Foundry is a unique offering in the venture capital market|Brad Feld,Co-Founder & Partner,Foundry Group
00:10:00
Governance Voice: Insights on CEO Succession and Board Evaluations with Beverly Beaudoin
00:10:00
Executive interview - Bigblu Broadband | Andrew Walwyn, CEO, Bigblu Broadband PLC (LON: BBB)
00:10:00
C4XD aims to efficiently deliver world leading immunoinflammatory medicines|Clive Dix,CEO,C4X Discovery Holdings